Viacell to present at Life Sciences Growth Conference and Chiron reports on initiation of a Phase I clinical trial of CHIR-258.

0 Comments | M2 Presswire, June, 2005

M2 PRESSWIRE-3 June 2005-US Financial Network: Viacell to present at Life Sciences Growth Conference and Chiron reports on initiation of a Phase I clinical trial of CHIR-258(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:03062005 City of Industry, CA - Defense industry news provided by Financial News USA (OTC: FNWU).

ViaCell, Inc. (Nasdaq: VIAC), announced today that Marc D. Beer, President and CEO, is scheduled to give a corporate update at the Pacific Growth Equities 2005 Life Sciences Growth Conference. The presentation is scheduled to occur on Tuesday, June 7, 2005 at 11:30 a.m. Pacific Time at the Mark Hopkins Intercontinental Hotel in San Francisco. Interested parties may access the live audio webcast of the presentation and replay it by visiting the ViaCell...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)